Overview|Leadership|Research |Communication & Outreach| Academic Requirements
Program OverviewStudents within DSRB address key questions in Developmental biology, Stem cell/niche interactions, and Regenerative Biology. The thread that unites these areas is the compelling drive to understand how tissues are first formed, how they are maintained, and how they can be repaired. The primary mission of DSRB faculty is to train students in hypothesis-driven research at the forefront of these areas.
Individualized Training:The curriculum in DSRB is set up to provide students with a strong foundation in fundamental developmental biology, as well as in stem cell and regenerative biology (see Academics). The curriculum is complemented by an Individualized Training Plan tailored to your background, to your interests, and to your career plans. You will develop this plan in consultation with faculty advisors, and take advantage of unique resources provided by the program, such as the extensive network of alumnae distributed among various post-PhD career paths.
Stunning Research Accomplishments:Evidence of the quality of research and the strength of the training plan is shown by the success rate among DSRB students who have applied for individual research training grants. Fully two-thirds of our students have been awarded NIH grants for their work (20/30; an unheard of 67% success rate). Those successes are spread across diverse areas of research within DSRB labs .
A Cohesive Program:We celebrate the diverse research within our community in our renowned Research-in-Progress Lunchtime series, where students present current work, with opportunity for discussion over good food. The series serves as one mechanism to polish communication skills and receive timely feedback, both on the science and on its presentation. Connections among our students are also reinforced by participation in the Developmental Biology Journal Club and the Student-invited Distinguished Lecturer Series. Our students support each other through a peer-mentoring program, and by running mock critique sessions to prepare for the oral Preliminary Exam and for fellowship proposals. Finally, students appointed to the Developmental Biology Training Grant (https://www.med.upenn.edu/dbtraininggrant/) are fully integrated into our program.
Continued Success as Your Career Progresses:Once students have received their PhD, their success continues as they leave our program and step onto their chosen path. Of the almost 50 DSRB students who received their PhD over the last 10 years, 90% went directly into academic research, medicine, the pharmaceutical or biotech industries.
PhiladelphiaMany other major Academic and Medical Institutions are right here, across Philadelphia, including the Childrens Hospital of Philadelphia, Fox Chase Cancer Center, The Wistar Institute, Thomas Jefferson University and several others. The Greater Philadelphia area has always been home to various Biotech and Pharma institutions. But, over the last five years it is becoming a hub for Next Generation therapeutics:http://www.phillymag.com/business/2017/06/17/cellacon-valley-philadelphia-medical-technology/ All of this converges to provide wonderful opportunities as you navigate your career choices.
This all can happen for you while experiencing an historical and vibrant city, alive with the Performing Arts, Culture, Sports and rich in world-class Museums and unique Collections. Both the University and the City of Philadelphia are incredibly diverse and welcoming communities, with opportunities for all: http://www.upenn.edu/life-at-penn.
DSRB Faculty Leadership & Committee Structure
DSRB Executive Committee:Jonathan Raper, Professor of NeuroscienceMichael Granato, Professor of Cell & Developmental BiologySarah Millar, Professor of DermatologyMontserrat Anguera, Assistant Professor of Animal Biology, the Vet SchoolCamille Syrett, DSRB Student Representative
DSRB Admissions Committee:Greg Bashaw, Professor of NeurosciencePaul Gadue, Associate Professor, Pathology & Lab Medicine
DSRB First year Advisors:Mary Mullins, Professor of Cell & Developmental BiologyMeera Sundaram, Professor of Genetics
DSRB Second (Prelim) year advisors:Paul Gadue, Associate Professor, Pathology & Lab Medicine Judith Grinspan, Professor of NeurologyWenqin Luo, Assistant Professor of NeurosciencePatrick Seale, Associate Professor of Cell & Developmental Biology
DSRB Curriculum Committee:Dan Kessler, Professor of Cell & Developmental BiologyChris Lengner, Associate Professor of Animal BiologyMary Mullins, Professor of Cell & Developmental Biology
ResearchBreadth of Research in DSRBDSRB Students are exposed to interdisciplinary training in gametogenesis; embryonic and fetal development; nervous system development and its wiring; the genesis of tissues and organ systems as well as their homeostasis, metabolism and repair. Exciting work is unraveling the basic biology of these processes, as well as understanding the consequences of and working toward the amelioration of diseases affecting their function. Complementing these areas is work on Embryonic Stem Cells (ESCs) and Induced Pluripotent Stem Cells (iPSCs; patient-derived iPSCs), using genome-scale approaches to understand disease processes in vitro in order to develop cell replacement strategies for therapy. The proximity of the University of Pennsylvania Health System, a world-renowned academic medical center, provides unparalleled opportunity for translational research.
State-of-the-Art Tools at your disposalDSRB Students have at their disposal all the tools of the modern genomic era. For example, some students have been developing high-throughput and genomic-scale screens, using deep sequencing, ChIP-SEQ, RNAi tools or small molecule libraries, while others are capitalizing on classical genetic analyses or CRISPR/Cas9-based screens. Some have been utilizing high-resolution microscopy techniques, including live-imaging of cells, organs and tissues in vivo, while others have adapted novel biochemical, epigenetic and cell biological approaches to their questions. Some students are actively isolating and manipulating ESCs and iPSCs, as well as characterizing the nuclear reprogramming events required to coax these cells into distinct neuroepithelial, mesodermal or endodermal lineages, an essential step in taking these powerful, biomedically promising entities into the clinic. Facilitating this work is access to world-class cores, including those for Next Generation Sequencing, Proteomics, the Zebrafish facility, Stem cell & Xenografting, and Microscopy (http://www.med.upenn.edu/cores/).
Expansive Choice of Systems in which to workYou have the opportunity to choose among a wide variety of experimental model systems. This facilitates comparative and collaborative work, and can significantly speed your work. For example, you might begin attacking a question in a system that is highly adapted to a particular approach, and then can shift your work to another system more amenable to a different approach, or for addressing the follow-up part of the question. The systems used in DSRB labs include plants, such as Arabidopsis; the yeasts; several invertebrate organisms, such as the nematode worm, fruitfly and ant; various vertebrate models, such as zebra fish, the frog, chick, rat and mouse; and, of course, various pluripotent types of stem cells, both normal and patient-derived.
Links to the Faculty areas of research in DSRB:
GametogenesisEmbryo & Fetal developmentCell Migration, Polarity and Morphogenesis Neurogenesis and Axonogenesis Tissue & Organ FormationStem Cell/Niche Interactions Regenerative Biology Epigenetics, gene regulatory networks & signal integration
Communication & Outreach
Communicating your science:An important facet of your training is developing the ability to communicate effectively and interact productively with scientific peers. For this reason, the DSRB program uses several mechanisms to promote communication of your research. This includes the popular student research-in-progress lunches -- a very successful forum, fostering cohesion among the students in DSRB. Communication skills are also sharpened by opportunities to host student-invited seminar speakers; to give presentations at various symposia, such as the CAMB Graduate Symposium, various Departmental or Institute symposia, and, of course, at National and International meetings.
Outreach to the Next GenerationStudents trained in DSRB have an important responsibility to enhance scientific and technological understanding within our communities. We want our students to convey to diverse audiences the general excitement about DSRB research as well as of their own specific accomplishments. For these reasons, we support and encourage the participation in any of several acclaimed outreach activities. Opportunities range from a semester as a teaching assistant to participation in a nationally renowned outreach program, or mentoring an intern in a research project for a summer. An appropriate time for our graduate students to participate in outreach would be in the middle-to-out years of their work, when coursework is complete and a thesis project is solidly underway.
-- BioEYES: with over 12 years in area public schools, the program is run by Dr. Jamie Shuda, an experienced educator who develops university-community partnerships in science. She will provide training, help establish relationships with students and teachers, and serve as a mentor to help assess impact and effectiveness. Students are encouraged to adapt the existing programs to best communicate their research focus to the most appropriate audience. http://bioeyes.org/index.html
-- The Summer Undergraduate Internship Program (SUIP):http://www.med.upenn.edu/bgs/applicants_suip.shtmlRun successfully by Biomedical Graduate Studies for over 15 years, the program serves some 30 college interns each summer, and particularly so those from underrepresented minority groups or disadvantaged backgrounds, those with disabilities, or who attend small colleges. In this program you will directly oversee the interns research in collaboration with your PI, and coach them in their summers end presentation to the Leadership Alliance National Symposium.
-- Mentoring local high school students in STEM science fair projects (Science, Technology, Engineering & Math); Running our DSRB booth at the Philadelphia Science on the parkway fair.
Academics
Program course requirementsTypical course & research schedule for DSRB students:
Fall of first year:- Cell Biology (BIOM 600)- First year seminar (literature readings + discussions; CAMB 605)- Lab Rotation #1 (11 weeks)
Spring of first year: - Regulation of the Genome (BIOM 555)- Biological Data Analysis (BIOM 611) - Principles of Development (required for DSRB; CAMB 511) - Lab Rotations #2 & #3 (each lasting 11 weeks)
Summer between first & second year:- Research in prospective thesis lab
Fall of second year:- Required for DSRB: one of two concept-based, seminar offerings:
- Neurodevelopment, Regeneration & Repair Seminar (Bashaw & Luo; CAMB 597).The course integrates neural specification & development, with essential functions of neurons in guidance, synapse formation and function, along with neural regeneration & repair.
- Stem Cells (Gadue & Rompolas; CAMB 697) This course covers the challenges in stem cell & regeneration biology including reprogramming, embryonic and tissue-specific stem cells, tissue regeneration, and tissue engineering.
- One Elective: any graduate-level course selected based on research interest (can also be whichever of the above was not chosen to satisfy the DSRB requirement)
- Thesis lab Research
Spring of second year:
- Two Electives: selected based on research interest- Prelim prep writing course (CAMB 695)- Thesis lab Research
Elective choices:Students have tremendous flexibility, and in consultation with faculty advisors will select electives that fit their research interests and prospective directions. Suggested electives:
CAMB 534:Seminar on Current Genetic ResearchCAMB 542:Topics in Molecular MedicineCAMB 550:Genetic PrinciplesCAMB 597:Neural Development, Regeneration and RepairCAMB 608:Regulation of Eukaryotic Gene ExpressionCAMB 632:Cell Control by Signal Transduction PathwaysCAMB 691/CAMB 692:Advanced Topics in Cell Biology and PhysiologyCAMB 697:The Biology of Stem CellsCAMB 709: Quantitative Imaging and Analysis for Biologists (QIAB)GCB 535: Introduction to BioInformaticsGCB 536: Computational BiologyBIOL 446: Statistics for BiologistsEPID 575: Introduction to Genetic Epidemiology
[top of page]
See the rest here:
University of Pennsylvania || Cell and Molecular Biology ...
- Kyle Orwig received the Distinguished Researcher Award from the American Society for Reproductive Medicine - University of Pittsburgh - October 4th, 2022
- I Have Cancer And I'm Thankful For The Life Science Industry - Clinical Leader - July 19th, 2022
- Whitmer to veto adoption, abortion alternative funds from Michigan budget - Bridge Michigan - July 19th, 2022
- Tevogen Bio Appoints Acclaimed Oncologist and Immunotherapy Expert Neal Flomenberg, M.D. as Chief Scientific Officer and Global Head of R&D - Yahoo... - July 11th, 2022
- Amendment added to PA budget bill would make Pitt, other universities stop fetal tissue research - WPXI Pittsburgh - July 3rd, 2022
- Free Fecal Water Syndrome in Horses and What To Do About It The Horse - TheHorse.com - July 3rd, 2022
- PAWcast: Valedictorian Natalia Orlovsky '22 on Research, Mental Health, and Pandemic Princeton - Princeton Alumni Weekly - July 3rd, 2022
- Opinion | Pro-Life Representatives may be the reason thousands of students cant afford Pitt - The Pitt News - June 22nd, 2022
- Tackling chronic disease with gene and cell therapies - The Irish Times - May 2nd, 2022
- How one inflammatory disorder exacerbates another | Penn Today - Penn Today - May 2nd, 2022
- ChristianaCare and The Wistar Institute Advance Partnership With New Cancer Research Strategies - ChristianaCare News - March 25th, 2022
- The Incredible Story of Emily Whitehead & CAR T-Cell Therapy : Oncology Times - LWW Journals - March 25th, 2022
- Penn State recipients of Whitaker Center's Women of Impact 2021 awards unite through research - The Daily Collegian Online - March 25th, 2022
- Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling Need to Salvage Central Venous Catheters in CLABSI Patients - Stockhouse - October 28th, 2021
- NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases - National Institutes of Health - October 28th, 2021
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases - FDA.gov - October 28th, 2021
- People and places at Penn | Penn Today - Penn Today - Penn Today - August 18th, 2021
- Millions in federal money flowed to tissue bank that collected fetal 'heart, gonads, legs, brain': report - Fox News - August 5th, 2021
- Bispecific Antibodies Wage a Two-Pronged Attack on Tumors - Curetoday.com - June 23rd, 2021
- Newly Discovered Glycosylated RNA Is All Over Cells: Study - The Scientist - May 25th, 2021
- Penn researchers find a way through the labyrinth keeping CAR-T from solid tumors - Endpoints News - December 7th, 2020
- 'Benjamin Button' discovery could reverse ageing process - Queensland Times - December 7th, 2020
- The story of mRNA: From a loose idea to a tool that may help curb Covid - STAT - November 11th, 2020
- Dr. Andreas Sauerbrey: The right orthopaedic diagnosis is essential to proper care - Sky Hi News - September 12th, 2020
- T cells, B cells and the range of the human bodys immune response A simple decoder - ThePrint - August 10th, 2020
- Are very long-lived trees immortal and what can they teach humans? - ABC News - August 10th, 2020
- Eradicating balding a step closer with new procedure in the cross hairs - The New Daily - June 4th, 2020
- Coming Together to Solve COVID-19 Mysteries | University of Pennsylvania Almanac - UPENN Almanac - June 4th, 2020
- Orthopedics - Pennsylvania Stem Cell Center - May 25th, 2020
- Stem Cell Treatment Bala Cynwyd | Stem Cell Therapy ... - May 25th, 2020
- Vasomune Therapeutics Announces Clinical and Scientific Advisory Board - BioSpace - May 11th, 2020
- Chinas scientists accused of playing God by creating monstrous cloned apes and primates with human organs - The Sun - May 11th, 2020
- Pregnant and positive | Scientists look for COVID-19 immunity in the womb - WHAS11.com - April 23rd, 2020
- Why Choose Us - Pennsylvania Stem Cell Center - April 10th, 2020
- Moderna: A $12 Billion Brand Built On Hope And mRNA - Seeking Alpha - April 10th, 2020
- The potential use of CRISPR to treat disease is gaining momentum - BioNews - January 16th, 2020
- What a time to be alive: Reproductive breakthroughs of the 2010s that changed life as we know it - FOX 10 News Phoenix - January 3rd, 2020
- 2019: The year gene therapy came of age - Jamaica Observer - December 9th, 2019
- Trevena Inc. (TRVN)'s Financial Results Comparing With VistaGen Therapeutics Inc. (NASDAQ:VTGN) - The Broch Herald - December 9th, 2019
- 253 miles in 4 hours: A Syracuse mans race for a lung transplant, and the angel who helped him - syracuse.com - December 1st, 2019
- Head to Head Survey: BioRestorative Therapies (OTCMKTS:BRTX) & Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - December 1st, 2019
- Critical Review: BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - NCTY News - November 16th, 2019
- These Israeli Companies Are Finding Innovative Ways To Improve Diabetes Care, Treatment | Health News - NoCamels - Israeli Innovation News - November 16th, 2019
- Reviewing BioRestorative Therapies (OTCMKTS:BRTX) and Livongo Health (OTCMKTS:LVGO) - Mitchell Messenger - November 16th, 2019
- Reviewing Madrigal Pharmaceuticals Inc. (MDGL)'s and Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI)'s results - MS Wkly - October 30th, 2019
- Gene Therapy/Editing Series 1: A Brief Introduction To Gene Therapy - Seeking Alpha - October 30th, 2019
- AI uncovers genes linked to heart failure - FierceBiotech - September 27th, 2019
- Robert Lanza - Wikipedia - May 12th, 2019
- Cary Ortho Utilizes Bone Marrow Stem Cells for General ... - May 12th, 2019
- Stem Cell Therapy in Lancaster Pennsylvania | Stem Cell ... - April 24th, 2019
- Lung Institute Review | Do Stem Cell Treatments Work? - April 21st, 2019
- Cells Weekly October 11, 2015 - stemcellassays.com - February 5th, 2019
- Pittsburgh, Pennsylvania - Stem Cells Transplant Institute - November 18th, 2018
- Stem Cell Therapy in York County, Pennsylvania - October 8th, 2018
- Regrowing dental tissue with stem cells from baby teeth ... - October 2nd, 2018
- About Penn's IRM - Institute for Regenerative Medicine - September 16th, 2018
- Stem Cell Treatment - Philadelphia Bala Cynwyd, PA: World ... - August 13th, 2018
- Stem Cell Therapy in Conewago Township, Pennsylvania - July 19th, 2018
- Meetings - October 8th, 2017
- Tucson's Calimmune to be acquired by Australian drug giant - Arizona Daily Star - August 30th, 2017
- Hair Regrowth using Stem Cells | Ashley and Martin - August 30th, 2017
- Bone Marrow Protein May Be Target for Improving Stem Cell Transplants - Penn: Office of University Communications - August 30th, 2017
- Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah(TM) (CTL019), for children and young ... - GlobeNewswire (press release) - August 30th, 2017
- COLUMN: Startling statistics concerning drug deaths in rural communities - Meadville Tribune - August 25th, 2017
- Rare leukemia targeted by modifying patients' immune cells - New Haven Register - August 7th, 2017
- Campus achievement - Sunbury Daily Item - August 7th, 2017
- La Jolla Light News Nuggets: July 27 - La Jolla Light - July 30th, 2017
- 2016 Scientific Program - December 4th, 2016
- Tissue Niches & Resident Stem Cells in Adult Epithelia - GRC - August 26th, 2016
- Knee Stem Cell Therapy and Platelet Procedures Pittsburgh ... - July 2nd, 2015
- Penn vet team points to new colon cancer culprit - March 16th, 2015
- MD Anderson Names Hwu as Head of Cancer Medicine - February 26th, 2015
- Stemiotics Licenses Modified RNA for Cell Reprogramming - December 22nd, 2014
- Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019 - December 8th, 2014
- Cyanide killed hospital employee, official says - November 29th, 2014
- An Eclectic Path to Precision Medicine - November 25th, 2014
- First Study to Convert Adult Human Cells to Hair-Follicle ... - November 2nd, 2014
- Stem Cell and Xenograft Core: Biomedical Research Core ... - October 27th, 2014
- Immune Therapy Induces Remission for Many With a Tough-to-Treat Blood Cancer - October 18th, 2014
- Sangamo BioSciences ZFP Therapeutic Program in HIV/AIDS Featured at Three Major Scientific Conferences in October 2014 - October 16th, 2014